Quick Answer
CalciMedica, Inc. reported Cash and Equivalents of $11.52 million for fiscal year 2025.
CalciMedica, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $11.52M | +45.2% |
| 2024 | $7.93M | +43.5% |
| 2023 | $5.53M | +316.7% |
| 2022 | $1.33M | -90.1% |
| 2021 | $13.36M | -60.0% |
| 2020 | $33.42M | +110.6% |
| 2019 | $15.87M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.47M | -40.2% | -7.6% |
| June 30, 2025 | $5.92M | +17.0% | -52.9% |
| March 31, 2025 | $12.56M | +85.9% | +58.2% |
| December 31, 2024 | $7.93M | +43.5% | -13.3% |
| September 30, 2024 | $9.15M | -21.4% | +81.0% |
| June 30, 2024 | $5.06M | -73.5% | -25.2% |
| March 31, 2024 | $6.75M | -72.3% | +22.2% |
| December 31, 2023 | $5.53M | +316.7% | -52.5% |
- CalciMedica, Inc. showed an increase of +45.2% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2019–2025 period, CalciMedica, Inc.’s cash and equivalents has declined by 27.4% (from $15.87 million to $11.52 million).
- The most recent figure is from CalciMedica, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: